Autor segons l'article: Benaiges, Ester; Ceperuelo-Mallafre, Victoria; Guaita, Sandra; Maymo-Masip, Elsa; Madeira, Ana; Gomez, David; Hernandez, Victor; Vilaseca, Isabel; Merma, Carla; Leon, Xavier; Terra, Ximena; Vendrell, Joan; Aviles-Jurado, Francesc Xavier; Fernandez-Veledo, Sonia
Departament: Medicina i Cirurgia Ciències Mèdiques Bàsiques Bioquímica i Biotecnologia
Autor/s de la URV: Avilés Jurado, Francisco Javier / Benaiges Moragrega, Ester / Ceperuelo Mallafré, Maria Victoria / Fernandez Veledo, Sonia / Gómez Gómez, David / GUAITA ESTERUELAS, SANDRA / Hernandez Masgrau, Victor / Maymo Masip, Elsa / Merma Linares, Carla Vanessa / Terra Barbadora, Ximena / Vendrell Ortega, Juan José
Paraules clau: Therapeutic target Survivin Squamous cell carcinoma of head and neck Radiotherapy Radioresistance Radiation tolerance Prognosis Middle aged Male Inhibitor of apoptosis proteins Humans Hnscc Head and neck neoplasms Glucose metabolism Glucose Female Disease-free survival Cell line, tumor Carcinoma, squamous cell Birc5 protein, human Biomarkers, tumor Aged Adult survivin radiotherapy radioresistance radiation hnscc expression cancer-cells apoptosis
Resum: Metabolic reprogramming and abnormal glucose metabolism are hallmarks of head and neck squamous cell carcinoma (HNSCC). Certain oncogenes can promote cancer-related metabolic changes, but understanding their crosstalk in HNSCC biology and treatment is essential for identifying predictive biomarkers and developing target therapies.We assessed the value of survivin/BIRC5 as a radioresistance factor potentially modulated by glucose for predicting therapeutic sensitivity and prognosis of HNSCC in a cohort of 32 patients. Additionally, we conducted in vitro experiments to explore the role of survivin/BIRC5 in glucose metabolism concerning radiation response.Tumoral BIRC5 expression is associated with serum glucose and predicts locoregional disease-free survival and lower BIRC5 mRNA levels are associated with better outcomes. Upregulation of BIRC5 by radiation depends on glucose levels and provokes a pro-tumoral and radioresistant phenotype in surviving cells.Survivin/BIRC5 might be independently associated with the risk of recurrence in patients with HNSCC.© 2024 The Authors. Head & Neck published by Wiley Periodicals LLC.
Àrees temàtiques: Surgery Saúde coletiva Otorhinolaryngology Odontología Medicina iii Medicina ii Medicina i Interdisciplinar General medicine Farmacia Engenharias iv Ciências biológicas iii Ciências biológicas ii Ciências biológicas i Biotecnología
Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
Adreça de correu electrònic de l'autor: david.gomez@urv.cat victor.hernandez@urv.cat carlavanessa.merma@urv.cat elsa.maymo@urv.cat victoria.ceperuelo@urv.cat franciscojavier.aviles@urv.cat carlavanessa.merma@urv.cat ester.benaiges@estudiants.urv.cat ester.benaiges@estudiants.urv.cat sonia.fernandez@urv.cat ximena.terra@urv.cat juanjose.vendrell@urv.cat
Identificador de l'autor: 0000-0003-3770-8486 0000-0002-9133-3120 0000-0002-4460-9761 0000-0001-5560-8097 0000-0003-2906-3788 0000-0003-1043-5844 0000-0002-6994-6115
Data d'alta del registre: 2024-10-12
Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
Referència a l'article segons font original: Head And Neck-Journal For The Sciences And Specialties Of The Head And Neck. 46 (7): 1752-1765
Referència de l'ítem segons les normes APA: Benaiges, Ester; Ceperuelo-Mallafre, Victoria; Guaita, Sandra; Maymo-Masip, Elsa; Madeira, Ana; Gomez, David; Hernandez, Victor; Vilaseca, Isabel; Mer (2024). Survivin/BIRC5 as a novel molecular effector at the crossroads of glucose metabolism and radioresistance in head and neck squamous cell carcinoma. Head And Neck-Journal For The Sciences And Specialties Of The Head And Neck, 46(7), 1752-1765. DOI: 10.1002/hed.27651
Entitat: Universitat Rovira i Virgili
Any de publicació de la revista: 2024
Tipus de publicació: Journal Publications
Repositori URV